Skip to main content

Table 3 Parkinson’s disease, RBD and control case information from ante-mortem CSF and serum received from OPDC

From: Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease

 Control subjectsPD subjectsRBD subjects
Cohort size153030
Female (%)53.350.013.3
Male (%)46.750.086.7
Age (years)66.2 ± 8.463.8 ± 9.964.4 ± 11.6
H&Y scoreN/AScore 1: n = 6
Score 2: n = 21
Score 3: n = 3
N/A
  1. RBD REM sleep behaviour disorder. Only serum was available for RBD cases. Data summarised as mean ± SD